Back to Search Start Over

Chitosan and chito-oligosaccharide: a versatile biopolymer with endless grafting possibilities for multifarious applications.

Authors :
Mohite P
Shah SR
Singh S
Rajput T
Munde S
Ade N
Prajapati BG
Paliwal H
Mori DD
Dudhrejiya AV
Source :
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2023 May 19; Vol. 11, pp. 1190879. Date of Electronic Publication: 2023 May 19 (Print Publication: 2023).
Publication Year :
2023

Abstract

Chito-oligosaccharides (COS), derived from chitosan (CH), are attracting increasing attention as drug delivery carriers due to their biocompatibility, biodegradability, and mucoadhesive properties. Grafting, the process of chemically modifying CH/COS by adding side chains, has been used to improve their drug delivery performance by enhancing their stability, targeted delivery, and controlled release. In this review, we aim to provide an in-depth study on the recent advances in the grafting of CH/COS for multifarious applications. Moreover, the various strategies and techniques used for grafting, including chemical modification, enzymatic modification, and physical modification, are elaborated. The properties of grafted CH/COS, such as stability, solubility, and biocompatibility, were reported. Additionally, the review detailed the various applications of grafted CH/COS in drug delivery, including the delivery of small drug molecule, proteins, and RNA interference therapeutics. Furthermore, the effectiveness of grafted CH/COS in improving the pharmacokinetics and pharmacodynamics of drugs was included. Finally, the challenges and limitations associated with the use of grafted CH/COS for drug delivery and outline directions for future research are addressed. The insights provided in this review will be valuable for researchers and drug development professionals interested in the application of grafted CH/COS for multifarious applications.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Mohite, Shah, Singh, Rajput, Munde, Ade, Prajapati, Paliwal, Mori and Dudhrejiya.)

Details

Language :
English
ISSN :
2296-4185
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in bioengineering and biotechnology
Publication Type :
Academic Journal
Accession number :
37274159
Full Text :
https://doi.org/10.3389/fbioe.2023.1190879